Stock 688578 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Shanghai Allist Pharmaceuticals Co., Ltd.

Equities

688578

CNE100005XJ7

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
62.97 CNY +1.73% Intraday chart for Shanghai Allist Pharmaceuticals Co., Ltd. +9.30% +51.15%
May. 09 Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib MT
Apr. 25 Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
AQ
InnoCare Announces Approval of Clinical Trial of SHP2 Inhibitor ICP-189 in Combination with EGFR Inhibitor Furmonertinib
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688578 Stock
  4. News Shanghai Allist Pharmaceuticals Co., Ltd.
  5. Press Releases